Maverick Advocaten assists Erasmus MC and LUMC in obtaining approval for joint venture

Martijn van de Hel and Ramesh Kaushik have assisted academic hospitals Erasmus MC and LUMC in obtaining approval from the NZa and ACM for the acquisition of joint control over GenomeScan. GenomeScan is a laboratory that provides innovative DNA analyses for diagnostics and genetic laboratory research.

Both the NZa and ACM approved early 2019 that Erasmus MC, together with existing shareholders LUMC and Genomic Investments, may acquire control over GenomeScan.

Follow Maverick Advocaten on Twitter and LinkedIn

Contact details

Martijn van de Hel

T +31 20 238 20 02
M +31 6 21 210 853

Ramesh Kaushik

T +31 20 238 20 14
M +31 6 47 000 133